Portfolio company
Freedom
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops ketamine and psychedelic combination therapies to treat patients with mental health conditions and substance use disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Freedom Biosciences
The company develops ketamine and psychedelic therapeutics for patients suffering from treatment-resistant depression and other mental health conditions.
Enabling psychedelics-assisted therapies
This biopharmaceutical company develops psychedelic-inspired medicines and a care delivery model to treat addiction for patients and healthcare providers.
GH Research
This pharmaceutical company develops psychedelic-based therapies for patients suffering from psychiatric and neurological disorders, including treatment-resistant depression.
Mindstate Design Labs
This biotechnology company develops custom psychedelic therapeutics using an artificial intelligence platform to treat mental health conditions for patients with various psychiatric disorders.
Compass Pathways
This biotechnology company develops psilocybin-based therapies for patients living with treatment-resistant depression and other mental health conditions.
Small Pharma Limited
This clinical-stage biotechnology company develops psychedelic-based medicines and DMT therapies for patients with major depressive disorder and other mental health conditions.
Gilgamesh
This clinical-stage biotechnology company develops novel psychedelic-related medicines and chemical entities to treat patients with depression and other neuropsychiatric disorders.
Psyon
This company provides psychedelic-assisted psychotherapy and psychiatric care to patients seeking treatment for mental health disorders.
